Drug Trial Radar · NCT03309163
Effect of Tramadol in Prevention of Postpartum Depression
Last checked: Nov 19, 2026Latest source record: Aug 14, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,230
Actual
Start
Oct 9, 2017
Primary completion
Jun 13, 2019
Study completion Aug 13, 2019
Sponsor
- Lead sponsor
- Xinqiao Hospital of ChongqingAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 13, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- Female only, from 20 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The incidence of postpartum depression in Europe and the United States is about 10%, while in China the incidence rate of 15.7-39.8%. Postpartum depression is one of the most common diseases of perinatal distress, but the current research of high-quality prevention and treatment of postpartum depression is still very lack. The study suggests that the risk of postpartum depression in cesarean delivery is significantly higher than that in vaginal delivery. Therefore, postpartum depression in cesarean delivery may require more attention and treatment.Tramadol is a non-opioid central analgesic that relieves common to severe pain, and tramadol has an inhibitory effect on norepinephrine and serotonin systems and has the potential to reduce depression and anxiety. Therefore, for the analgesic demand and antidepressant demand for maternal who undergoing cesarean section, tramadol may be an optimized and effective analgesic for the prevention and treatment of postpartum depression.
Conditions
- Caesarean Section
Interventions
TramadolDrug
Patient-controlled intravenous analgesia with Tramadol
HydromorphoneDrug
Patient-controlled intravenous analgesia with Hydromorphone
Ropivacaine (Epidural analgesia)Drug
Patient-controlled epidural analgesia with Ropivacaine.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The incidence of postpartum depressionTime frame: At 4 weeks after the surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Xinqiao Hospital, Third Military Medical University
Chongqing, Chongqing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.